Omeros Announces National Institute on Drug Abuse’s Support for Phase 2 Clinical Study in Addiction Program (redOrbit)

More info…
SEATTLE, Jan. 28 /PRNewswire-FirstCall/ — Omeros Corporation (Nasdaq: OMER) today announced that the National Institute on Drug Abuse (NIDA) is providing support for the Company’s Addiction program.